After months of collaboration and technical preparation, iQHT has successfully migrated iQemo from UKFast to Microsoft Azure. This marks a major milestone in improving performance, resilience, and scalability across all supported NHS sites and private healthcare providers. This was made possible through the dedicated efforts of their clinical and technical teams alongside our own. Together we laid the foundation for future innovation.
Azure provides the scale, flexibility, and security needed to power iQemo’s next chapter across a growing network of NHS Trusts and private healthcare customers.
This wasn’t a simple lift-and-shift. It was a complex, multi-phase project involving:
Each go-live required detailed planning, downtime coordination, and careful validation to ensure patient safety and data integrity. We’re incredibly grateful to everyone who played a role in delivering this work with care and precision.
As with any major infrastructure change, some post-migration technical challenges did arise, including some connectivity inconsistencies during the initial transition period.
However, the cross-functional team responded quickly and worked together proactively to identify root causes, implement fixes, and restore full functionality. This responsiveness was key to maintaining clinician confidence and minimising disruption on the ground.
Now fully hosted on Azure, iQemo users will benefit from:
This migration puts us in a stronger position to scale and enhance iQemo in line with evolving needs.
With the migration complete, we’re now focused on:
This migration sets the stage for a faster, more resilient, and more secure iQemo experience for every customer. With Azure as our foundation, we can continue to evolve the platform and bring new features to clinicians and patients with greater speed and confidence. We look forward to building the next chapter of innovation together.
iQ HealthTech was established in 2011 by a founding-team of software developers and a practicing consultant oncologist. With a team of subject experts working across design, development, implentations and customer success, the company develops people-centric technology with the goal of improving patient outcomes, everywhere. The company delivers innovative Saas and standalone platforms, including iQemo – the industry-leading, end-to-end chemotherapy prescribing and management platform used by NHS and private hospitals in the UK, and a growing number of hospitals worldwide. Learn more
Sign up to our newsletter and stay updated with industry-leading advice, insight and more…
iQemo, from iQHealthTech, provides specialist chemotherapy prescribing. A complete end-to-end solution that includes predefined regimens, prescribing, scheduling and dispensing, through to chemotherapy administration and reporting. iQemo is used in NHS Trusts and private hospitals in the UK, and in a growing number of hospitals worldwide. Learn More
iQ HealthTech was established in 2011 by a founding-team of software developers and a practicing consultant oncologist. With a team of subject experts working across design, development, implentations and customer success, the company develops people-centric technology with the goal of improving patient outcomes, everywhere. Learn more
We'd love to discuss how iQemo could support your organisation, people and patients.
Get in touch